title: Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.
abstract: BACKGROUND
  The mechanism of action of bisacodyl in the unprepared human colon remains unclear.
  
  
  OBJECTIVE
  To evaluate the effect of oral bisacodyl on the overall and regional colonic transit in humans.
  
  
  METHODS
  In a double-blind, randomized, placebo-controlled study of 25 healthy participants, effects of oral bisacodyl (5 mg p.o. per day) and placebo on colonic transit were compared. A validated scintigraphy method was used to measure colonic transit. The primary transit endpoints, ascending colon emptying t(1/2) and geometric centre of colon isotope at 24 h (overall transit), were compared (Wilcoxon rank sum test).
  
  
  RESULTS
  There were significant treatment effects on ascending colon t(1/2), with the bisacodyl group demonstrating accelerated emptying [median 6.5 h, interquartile range 5.0-8.0 h] relative to the placebo group [11.0 h (7.0-17.1); P = 0.03]. Numerical differences in colonic geometric centre 24 h [bisacodyl median 3.0 (2.2-3.8), placebo 4.0 (3.1-4.6)] were not significant (P = 0.19). There were no significant differences observed in geometric centre 4 h.
  
  
  CONCLUSIONS
  Oral 5 mg bisacodyl accelerates ascending colon in the unprepared colon in healthy adults; this action may contribute to the drug's efficacy in constipation.
authors.affiliation: Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: N
authors.initials: N
authors.lastname: Manabe
authors.forename: F
authors.initials: F
authors.lastname: Cremonini
authors.forename: M
authors.initials: M
authors.lastname: Camilleri
authors.forename: W J
authors.initials: WJ
authors.lastname: Sandborn
authors.forename: D D
authors.initials: DD
authors.lastname: Burton
mesh_terms: D000293:Adolescent; D000328:Adult; D001726:Bisacodyl / Q000627:therapeutic use*; D002400:Cathartics / Q000627:therapeutic use*; D044682:Colon, Ascending / Q000000981:diagnostic imaging / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D005772:Gastrointestinal Transit / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D002400:Cathartics; D001726:Bisacodyl
references.citation: Gastroenterology. 1991 Jul;101(1):107-15
references.pmid: 2044899
references.citation: Aliment Pharmacol Ther. 2006 May 15;23(10):1479-88
references.pmid: 16669963
references.citation: Gut. 1988 Aug;29(8):1085-92
references.pmid: 3410334
references.citation: Lancet. 2000 Mar 25;355(9209):1035-40
references.pmid: 10744088
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G295-301
references.pmid: 19033530
references.citation: Aliment Pharmacol Ther. 1995 Feb;9(1):69-73
references.pmid: 7766747
references.citation: Neurogastroenterol Motil. 2004 Aug;16(4):397-402
references.pmid: 15305994
references.citation: Arzneimittelforschung. 1988 Apr;38(4):570-4
references.pmid: 3401271
references.citation: Gastroenterology. 2000 Jul;119(1):41-50
references.pmid: 10889153
references.citation: Can J Physiol Pharmacol. 1986 Jan;64(1):39-43
references.pmid: 3955442
references.citation: Digestion. 1999 Jan-Feb;60(1):69-73
references.pmid: 9892801
references.citation: Gastroenterology. 2001 Feb;120(2):354-60
references.pmid: 11159875
references.citation: Gastroenterology. 1978 Apr;74(4):698-703
references.pmid: 631507
references.citation: Eur J Pharmacol. 1985 Nov 5;117(2):215-22
references.pmid: 4076344
references.citation: Digestion. 1984;30(3):191-4
references.pmid: 6548720
references.citation: J Nucl Med. 1997 Nov;38(11):1807-10
references.pmid: 9374360
references.citation: Int J Colorectal Dis. 2008 Dec;23(12):1175-83
references.pmid: 18665373
references.citation: Drugs Aging. 1998 Sep;13(3):245-53
references.pmid: 9789728
references.citation: Aliment Pharmacol Ther. 2002 Oct;16(10):1781-90
references.pmid: 12269971
references.citation: Am J Gastroenterol. 2005 Apr;100(4):936-71
references.pmid: 15784043
references.citation: Int J Pharm. 2000 Feb 25;196(1):11-20
references.pmid: 10675703
references.citation: Mayo Clin Proc. 1990 Nov;65(11):1456-79
references.pmid: 2232900
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G942-7
references.pmid: 16603730
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1972;274(1):46-53
references.pmid: 4262724
references.citation: N Engl J Med. 1993 Oct 7;329(15):1073-8
references.pmid: 8371728
references.citation: Scand J Gastroenterol. 2008;43(5):545-50
references.pmid: 18415746
references.citation: Gastroenterology. 2007 Sep;133(3):761-8
references.pmid: 17854590
references.citation: Gut. 1974 Aug;15(8):599-607
references.pmid: 4419566
references.citation: Am J Physiol. 1990 Jun;258(6 Pt 1):G856-62
references.pmid: 2360632
references.citation: Aliment Pharmacol Ther. 2001 Oct;15(10):1655-66
references.pmid: 11564007
references.citation: J Pharmacol Exp Ther. 1994 Sep;270(3):1239-45
references.pmid: 7523656
references.citation: Dig Dis Sci. 2003 Jul;48(7):1206-12
references.pmid: 12870774
references.citation: Gastroenterology. 1992 Jul;103(1):36-42
references.pmid: 1612355
references.citation: Digestion. 1987;37(4):247-53
references.pmid: 3678638